TEUS Registry: Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study

Sponsor
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05051358
Collaborator
(none)
5,000
1
24
208.8

Study Details

Study Description

Brief Summary

The purpose of this retrospective chart-review registry study is to evaluate the safety profile, efficacy profile and cost-effectiveness of the various therapeutic endoscopic ultrasound (EUS) procedures (for benign and malignant gastrointestinal disorders).

  1. To assess the clinical and technical success rates of EUS-Guided interventions

  2. To document the impact of therapeutic EUS procedures on the management of gastrointestinal disorders including malignancies through cost effective analyses.

  3. Compare endoscopic interventions to non-endoscopic interventions for the same clinical indications and evaluate safety and efficacy.

Detailed Description

Our tertiary-care institution performs clinically-indicated therapeutic Endoscopic Ultrasound (TEUS) guided interventions, including biliary and pancreatic drainage, for both malignant and benign gastrointestinal indications in more than 2000 patients annually.

Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal disorders.

TEUS procedures are less invasive approach than surgery. Moreover, they can be available to patients who are ineligible for surgery or who have refused more aggressive surgical intervention.

They improve quality of life and extend survival duration.

Currently, there is limited multi-center data on therapeutic endoscopy clinical outcomes and standardized treatment algorithms in western populations. Due to continuing variations in therapeutic EUS procedures, as well as introduction of some TEUS procedure accessories; it is necessary to periodically evaluate the efficacy and safety of specific TEUS procedures and accessories for several indications to check for improved clinical outcomes.

Evaluation of these clinical details would help us compare them to conventional treatment modalities within our current facility and scope of practice; and consequently, help us identify safe and cost-effective treatment techniques, develop treatment algorithms and improve clinical management of patients at RWJMS and other tertiary-care centers.

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry
Actual Study Start Date :
Feb 11, 2021
Anticipated Primary Completion Date :
Dec 10, 2022
Anticipated Study Completion Date :
Feb 10, 2023

Arms and Interventions

Arm Intervention/Treatment
Subjects undergoing Therapeutic Endoscopic Ultrasound

Procedures that will be captured include: EUS- ERCP, Endoscopic Hepatology - EUS, EUS-Coils placement, EUS Glue injection, EUS-Fiducial placement, EUS-Neurolysis, EUS-Stent placement, EUS-alcohol injection, EUS-guided Ablation, EUS-guided anastomosis, EUS Guided ERCP for gallbladder, pancreatic duct or biliary duct drainage, EUS guided - Hemostasis, EUS guided- Therapy for cancer or premalignant lesion (Injection, neurolysis, fiducial, aspiration, RFA ), EUS - Fluid Collection, abscess or cavity drainage, EUS - Guided Ductal Drainage, EUS - Guided Anastomosis

Procedure: Therapeutic Endoscopic Ultrasound
Therapeutic Endoscopic Ultrasound or Interventional Endoscopy for Gastrointestinal Indications

Outcome Measures

Primary Outcome Measures

  1. Efficacy of Procedure [Upto 2 years]

    Technical and clinical success rates

  2. Safety of procedure [Upto 2 years]

    Type, frequency and intensity of adverse events

Secondary Outcome Measures

  1. Cost Effectiveness [Upto 2 years]

    Total cost associated with procedures

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects undergoing Interventional Therapeutic Endoscopic Ultrasound Procedures for Gastrointestinal indications
Exclusion Criteria:
  • Subjects not undergoing Interventional Therapeutic Endoscopic Ultrasound Procedures for Gastrointestinal indications

Contacts and Locations

Locations

Site City State Country Postal Code
1 Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University New Brunswick New Jersey United States 08901

Sponsors and Collaborators

  • Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University

Investigators

  • Principal Investigator: Michel Kahaleh, MD, Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
ClinicalTrials.gov Identifier:
NCT05051358
Other Study ID Numbers:
  • Pro2020002795
First Posted:
Sep 21, 2021
Last Update Posted:
Sep 21, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2021